Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 579

1.

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.

Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR; SPYRAL HTN-OFF MED Pivotal Investigators.

Lancet. 2020 Mar 27. pii: S0140-6736(20)30554-7. doi: 10.1016/S0140-6736(20)30554-7. [Epub ahead of print]

PMID:
32234534
2.

Lumen narrowing and increased wall to lumen ratio of retinal microcirculation are valuable biomarkers of hypertension-mediated cardiac damage.

Dąbrowska E, Harazny JM, Miszkowska-Nagórna E, Stefański A, Graff B, Kunicka K, Świerblewska E, Rojek A, Szyndler A, Wolf J, Gruchała M, Schmieder RE, Narkiewicz K.

Blood Press. 2019 Sep 5:1-10. doi: 10.1080/08037051.2019.1657769. [Epub ahead of print]

PMID:
32228237
3.

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.

Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Lüscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP, Sievert H, Volpe M, Weber MA, Schmieder RE, Tsioufis C, Wijns W.

Eur Heart J. 2020 Mar 25. pii: ehaa121. doi: 10.1093/eurheartj/ehaa121. [Epub ahead of print] No abstract available.

PMID:
32211888
4.

Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography.

Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder RE.

Sci Rep. 2020 Mar 24;10(1):5255. doi: 10.1038/s41598-020-61308-4.

5.

Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.

Gosk-Przybyłek M, Doroszko A, Dobrowolski P, Warchoł-Celińska E, Harazny J, Bińczyk E, Szymanek K, Pęczkowska M, Kabat M, Toutounchi S, Gałązka Z, Górnicka B, Szaflik J, Januszewicz M, Klisiewicz A, Hoffman P, Lenders JWM, Eisenhofer G, Szaflik JP, Schmieder RE, Prejbisz A, Januszewicz A.

J Hypertens. 2020 Mar 19. doi: 10.1097/HJH.0000000000002420. [Epub ahead of print]

PMID:
32205562
6.

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial.

Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, Fellström B, Settembre N, Malikov S, Rossignol P, Zannad F.

Clin Kidney J. 2019 May 11;13(1):116-122. doi: 10.1093/ckj/sfz048. eCollection 2020 Feb.

7.

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design.

Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Hickey GL, Fahy M, DeBruin V, Brar S, Pocock S.

Clin Res Cardiol. 2020 Mar;109(3):289-302. doi: 10.1007/s00392-020-01595-z. Epub 2020 Feb 7.

8.

Changes in Stroke Volume After Renal Denervation: Insight From Cardiac Magnetic Resonance Imaging.

Lurz P, Kresoja KP, Rommel KP, von Roeder M, Besler C, Lücke C, Gutberlet M, Schmieder RE, Mahfoud F, Thiele H, Desch S, Fengler K.

Hypertension. 2020 Mar;75(3):707-713. doi: 10.1161/HYPERTENSIONAHA.119.14310. Epub 2020 Feb 3.

PMID:
32008429
9.

Influence of Age on Upper Arm Cuff Blood Pressure Measurement.

Picone DS, Schultz MG, Otahal P, Black JA, Bos WJ, Chen CH, Cheng HM, Cremer A, Dwyer N, Fonseca R, Hughes AD, Kim HL, Lacy PS, Laugesen E, Ohte N, Omboni S, Ott C, Pereira T, Pucci G, Roberts-Thomson P, Rossen NB, Schmieder RE, Sueta D, Takazawa K, Wang J, Weber T, Westerhof BE, Williams B, Yamada H, Yamamoto E, Sharman JE; Invasive Blood Pressure Consortium.

Hypertension. 2020 Mar;75(3):844-850. doi: 10.1161/HYPERTENSIONAHA.119.13973. Epub 2020 Jan 27.

PMID:
31983305
10.

Facing the Challenge of Lowering Blood Pressure and Cholesterol in the Same Patient: Report of a Symposium at the European Society of Hypertension.

Williams B, Masi S, Wolf J, Schmieder RE.

Cardiol Ther. 2020 Jan 13. doi: 10.1007/s40119-019-00159-1. [Epub ahead of print] Review.

PMID:
31933276
11.

Aortic stiffness is not only associated with structural but also functional parameters of retinal microcirculation.

Dąbrowska E, Harazny JM, Miszkowska-Nagórna E, Stefański A, Graff B, Kunicka K, Świerblewska E, Rojek A, Szyndler A, Gąsecki D, Wolf J, Gruchała M, Laurent S, Schmieder RE, Narkiewicz K.

Microvasc Res. 2020 May;129:103974. doi: 10.1016/j.mvr.2020.103974. Epub 2020 Jan 7.

PMID:
31923388
12.

Medication adherence in hypertension.

Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, Schmieder RE.

J Hypertens. 2020 Apr;38(4):579-587. doi: 10.1097/HJH.0000000000002294.

PMID:
31834123
13.

Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes.

Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, Schmieder RE.

Eur Heart J Cardiovasc Pharmacother. 2019 Dec 9. pii: pvz078. doi: 10.1093/ehjcvp/pvz078. [Epub ahead of print]

PMID:
31816038
14.

Copeptin Levels in Patients With Treatment-Resistant Hypertension Before and 6 Months After Renal Denervation.

Bosch A, Schmid A, Ott C, Kannenkeril D, Karg MV, Ditting T, Veelken R, Uder M, Schmieder RE.

Am J Hypertens. 2020 Feb 22;33(2):182-189. doi: 10.1093/ajh/hpz155.

PMID:
31555795
15.

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy.

Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder RE, Kirtane AJ, Böhm M, Hettrick DA, Townsend RR, Tsioufis KP.

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11913081. doi: 10.1161/HYPERTENSIONAHA.119.13081. [Epub ahead of print] No abstract available.

16.

Evidence of neurodegeneration in individuals with only mildly elevated blood pressure.

Jung S, Bosch A, Kohler N, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder RE.

J Hypertens. 2019 Dec;37(12):2389-2397. doi: 10.1097/HJH.0000000000002164.

PMID:
31246897
17.

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.

Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1095-1105. doi: 10.1016/j.jcin.2019.02.050. Review.

PMID:
31221299
18.

Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review.

Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, DiBona GF, Everett TH 4th, Grassi G, Katholi RE, Knuepfer MM, Kopp UC, Lefer DJ, Lohmeier TE, May CN, Mahfoud F, Paton JFR, Schmieder RE, Pellegrino PR, Sharabi Y, Schlaich MP.

J Am Coll Cardiol. 2019 Jun 18;73(23):3006-3017. doi: 10.1016/j.jacc.2019.04.015. Review.

PMID:
31196459
19.

Tissue sodium content in patients with type 2 diabetes mellitus.

Kannenkeril D, Karg MV, Bosch A, Ott C, Linz P, Nagel AM, Uder M, Schmieder RE.

J Diabetes Complications. 2019 Jul;33(7):485-489. doi: 10.1016/j.jdiacomp.2019.04.006. Epub 2019 Apr 16.

PMID:
31101486
20.

Patient preference for therapies in hypertension: a cross-sectional survey of German patients.

Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C.

Clin Res Cardiol. 2019 Dec;108(12):1331-1342. doi: 10.1007/s00392-019-01468-0. Epub 2019 Apr 2.

PMID:
30941492
21.

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial.

Bosch A, Ott C, Jung S, Striepe K, Karg MV, Kannenkeril D, Dienemann T, Schmieder RE.

Cardiovasc Diabetol. 2019 Mar 29;18(1):44. doi: 10.1186/s12933-019-0839-8.

22.

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149.

PMID:
30919899
23.

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators.

Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451. [Epub ahead of print]

PMID:
30880441
24.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

Kardiol Pol. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. Polish. No abstract available.

25.

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience.

Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE.

Clin Exp Nephrol. 2019 Jun;23(6):749-755. doi: 10.1007/s10157-019-01697-7. Epub 2019 Feb 19.

PMID:
30783914
26.

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder RE, Eckardt KU.

Kidney Int Rep. 2018 Oct 11;4(2):267-274. doi: 10.1016/j.ekir.2018.10.004. eCollection 2019 Feb.

27.

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Mahfoud F, Böhm M, Bongarth CM, Bosch R, Schmieder RE, Schunkert H, Stellbrink C, Trenkwalder P, Vonend O, Weil J, Kreutz R.

Internist (Berl). 2019 Apr;60(4):424-430. doi: 10.1007/s00108-019-0576-9. Review. German.

PMID:
30770942
28.

Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.

Ott C, Bosch A, Winzer N, Friedrich S, Schinzel R, Tegtmeier F, Schmieder RE.

Br J Clin Pharmacol. 2019 May;85(5):900-907. doi: 10.1111/bcp.13870. Epub 2019 Feb 28.

PMID:
30666700
29.

[European guidelines for the management of arterial hypertension 2018-what has changed?]

Jung S, Schmieder RE.

Internist (Berl). 2019 Feb;60(2):202-208. doi: 10.1007/s00108-018-0552-9. Review. German.

PMID:
30649580
30.

Reply.

Schmieder RE, Mahfoud F.

J Hypertens. 2019 Feb;37(2):454. doi: 10.1097/HJH.0000000000001993. No abstract available.

PMID:
30640879
31.

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2020 Jan 7;41(2):231-238. doi: 10.1093/eurheartj/ehy808.

PMID:
30590564
32.

Secretory Capacity of Pancreatic Beta-Cells Is Enhanced 6 Months After Renal Denervation in Hypertensive Patients.

Ott C, Schmid A, Mahfoud F, Akarca E, Kistner I, Ditting T, Veelken R, Böhm M, Uder M, Schmieder RE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3372-3374. doi: 10.1016/j.jacc.2018.09.075. No abstract available.

33.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

G Ital Cardiol (Rome). 2018 Nov;19(11 Suppl 1):3S-73S. doi: 10.1714/3026.30245. Italian. No abstract available.

PMID:
30520455
34.

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP.

Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.

PMID:
30354716
35.

Interpretation of noninvasive retinal microvascular studies: the individual source of the automatic full field imaging analysis program has to be taken into account.

Harazny JM, Schmieder RE.

J Hypertens. 2018 Nov;36(11):2277. doi: 10.1097/HJH.0000000000001881. No abstract available.

PMID:
30256326
36.

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:.

J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940. Erratum in: J Hypertens. 2019 Jan;37(1):226.

PMID:
30234752
37.

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.

Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder RE.

Cardiovasc Diabetol. 2018 Sep 19;17(1):128. doi: 10.1186/s12933-018-0770-4.

38.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475.

PMID:
30165516
39.

Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up.

Jung S, Ott C, Karg MV, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder RE.

J Hypertens. 2018 Dec;36(12):2471-2477. doi: 10.1097/HJH.0000000000001873.

PMID:
30113527
40.

European Society of Hypertension position paper on renal denervation 2018.

Schmieder RE, Mahfoud F, Azizi M, Pathak A, Dimitriadis K, Kroon AA, Ott C, Scalise F, Mancia G, Tsioufis C; Members of the ESH Working Group on Interventional Treatment of Hypertension.

J Hypertens. 2018 Oct;36(10):2042-2048. doi: 10.1097/HJH.0000000000001858.

PMID:
30015759
41.

Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success.

Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL, Gupta A, Balawon A, Pheby J, Zak A, Rull G, O'Brien B, Schmieder RE, Lobo MD.

J Am Heart Assoc. 2018 Jun 12;7(12). pii: e009151. doi: 10.1161/JAHA.118.009151.

42.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators.

Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Erratum in: Lancet. 2018 Sep 8;392(10150):820.

PMID:
29803590
43.

Correction to: Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Apr 9;20(3):27. doi: 10.1007/s11906-018-0844-4.

PMID:
29629502
44.

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP.

Microvasc Res. 2018 Jul;118:121-127. doi: 10.1016/j.mvr.2018.03.008. Epub 2018 Mar 17.

PMID:
29559377
45.

Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Mar 19;20(3):18. doi: 10.1007/s11906-018-0816-8. Review. Erratum in: Curr Hypertens Rep. 2018 Apr 9;20(3):27.

PMID:
29556742
46.

Renal denervation improves 24-hour central and peripheral blood pressures, arterial stiffness, and peripheral resistance.

Ott C, Franzen KF, Graf T, Weil J, Schmieder RE, Reppel M, Mortensen K.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):366-372. doi: 10.1111/jch.13193. Epub 2018 Jan 25.

47.

Individualised treatment targets in patients with type-2 diabetes and hypertension.

Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK; DIALOGUE study group.

Cardiovasc Diabetol. 2018 Jan 22;17(1):18. doi: 10.1186/s12933-018-0661-8.

48.

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.

Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE.

Cardiovasc Diabetol. 2018 Jan 4;17(1):5. doi: 10.1186/s12933-017-0654-z.

49.

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE.

BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x.

50.

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.

Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M.

Am Heart J. 2018 Jan;195:115-129. doi: 10.1016/j.ahj.2017.09.006. Epub 2017 Sep 12.

PMID:
29224639

Supplemental Content

Loading ...
Support Center